
Artificial intelligence (AI) is making profound impacts on drug development in Japan, working to dramatically cut research timelines and costs through pioneering “pharmaceutical AI” projects. In this transformative era, AI algorithms are applied to analyze extensive electron microscopy images of virus and bacteria proteins, thereby predicting morphological changes. This analysis is pivotal for understanding infection mechanisms, essential in the development










